Emily Ko

Emily Ko is a gynecologic oncologist whose research focuses on clear cell histology in both endometrial and ovarian cancers, which are biologically distinct from endometrioid and serous types and are enriched for ARID1A and PI3K pathway alterations. She has contributed to translational studies demonstrating that clear cell gynecologic cancers have distinct tumor microenvironment features and variable immunotherapy responses, and has participated in basket trial designs targeting ARID1A-deficient tumors. She also investigates mismatch repair protein loss patterns in clear cell endometrial carcinoma.